Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years (CanBenefitII)
Lung Neoplasm Malignant, Mesothelioma; Lung
About this trial
This is an interventional treatment trial for Lung Neoplasm Malignant focused on measuring Physical Activity, Nutrition, Feasibility RCT, Lung cancer, Older adults
Eligibility Criteria
Inclusion Criteria:
- age ≥65 years,
- diagnosed with stage III or IV lung cancer or mesothelioma,
- starting a new line of systemic anti-cancer treatment,
- willing and able to complete study measures and be randomised
- able to provide informed written or verbal witnessed consent
Exclusion Criteria:
- Patients receiving radical chemoradiation therapy (potentially curative and require parental feeding)
- Have had more than one dose of new treatment.
- Unstable acute condition (e.g., acute infection, severe uncontrolled symptoms) or
- Underlying chronic condition (e.g., severe arthritis or dementia) that would impact study compliance.
- Unable to provide written or verbal consent.
- Insufficient English for consent and study procedures and appropriate interpretation unavailable
Sites / Locations
- Hull University Teaching Hospitals NHS Trust
- York and Scarborough Teaching Hospitals NHS Trust
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention arm
Usual care arm
12 weeks home based tailored nutrition and physical activity (PA) programme Participants will have an appointment (face-to-face if possible) with the study physiotherapist and dietitian for delivery of the PA (including breathlessness management) and nutrition intervention components. Participants will receive study equipment at these appointments (or by post) including paper-based tracking diary, resistance bands for strength exercises, a Fitbit activity monitor to track steps and aerobic activity during the study period, nutritional supplements (if prescribed), and printed study materials (if preferred over pdf emails; e.g. cooking tips, recipes). A video/telephone follow-up call (10-15 minutes) will be conducted by the research team with the participant at weeks 2,3,4,5 and 6 and then at weeks 8,10 and 12 to review and adjust their programme (with input from the physiotherapist and dietitian if required).
The usual cancer care will include usual patient management and care prior, during and after cancer treatment - medication, symptom control, cancer advice and support from routine medical and nursing input with access to Allied Health Professionals (AHPs) such as physiotherapists and dietitians as clinically indicated. As part of this, it is common for older adults with cancer to be prescribed high protein supplementation. Control participants will receive a general information leaflet regarding activity and nutrition.